KalVista Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending July 31, 2024 was -0.87 USD/shares, a 17.6% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending July 31, 2024 was -3.57 USD/shares, a 14.1% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.44 USD/shares, a 3.3% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.33 USD/shares, a 0.89% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -3.36 USD/shares, a 38.8% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 $0 -3.3% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 -$3 +$0.03 +0.89% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 -$3 -$1 -38.8% May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 -$2 -$1 -47.6% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 -$2 May 1, 2019 Apr 30, 2020 10-K 2022-07-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.